Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia
Movement Disorders · 2024
DOI: 10.1002/mds.29741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Luca Pollini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Electroencephalography, Myoclonus, Electromyography, Qb-SNARE Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Negative myoclonus (NM) is an involuntary movement caused by a sudden interruption of muscular activity, resulting in gait problems and falls.
Objective
To establish frequency, clinical impact, and neurophysiology of NM in progressive myoclonus ataxia (PMA) patients.
Methods
Clinical, neurophysiological, and genetic data of 14 PMA individuals from University Medical Centre Groningen (UMCG) Expertise Center Movement Disorder Groningen were retrospectively collected. Neurophysiological examination included video‐electromyography‐accelerometry assessment in all patients and electroencephalography (EEG) examination in 13 individuals. Jerk‐locked (or silent period‐locked) back‐averaging and cortico‐muscular coherence (CMC) analysis aided the classification of myoclonus.
Results
NM was present in 6 (NM+) and absent in 8 (NM−) PMA patients. NM+ individuals have more frequent falls (100% vs. 37.5%) and higher scores on the Gross Motor Function Classification System (GMFCS) (4.3 ±0.74 vs. 2.5 ±1.2) than NM− individuals. Genetic background of NM+ included GOSR2 and SEMA6B , while that of NM− included ATM , KCNC3 , NUS1 , STPBN2 , and GOSR2 . NM was frequently preceded by positive myoclonus (PM) and silent‐period length was between 88 and 194 ms. EEG epileptiform discharges were associated with NM in 2 cases. PM was classified as cortical in 5 NM+ and 2 NM− through EEG inspection, jerk‐locked back‐averaging, or CMC analysis.
Discussion
Neurophysiological examination is crucial for detecting NM that could be missed on clinical examination due to a preceding PM. Evidence points to a cortical origin of NM, an association with more severe motor phenotype, and suggests the presence of genetic disorders causing either a PMA or progressive myoclonus epilepsy, rather than pure PMA phenotype. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
- Department of Neurology, University of Groningen, University Medical Centre Groningen (UMCG), Groningen, The Netherlands.
- Expertise Centre Movement Disorders Groningen, University Medical Centre Groningen (UMCG), Groningen, The Netherlands.
- Department of Clinical Neurophysiology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
ORCID-Profile: Luca Pollini, Marina A J Tijssen
Zitieren
APA
Pollini, L., van der Veen, S., Elting, J. W. J., & Tijssen, M. A. J. (2024). Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia. Movement Disorders. https://doi.org/10.1002/mds.29741
Vancouver
Pollini L, van der Veen S, Elting JWJ, Tijssen MAJ. Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia. Movement Disorders. 2024. doi:10.1002/mds.29741
BibTeX
@article{Pollini2024,
author = {Pollini, Luca and van der Veen, Sterre and Elting, Jan Willem J and Tijssen, Marina A J},
title = {Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia},
journal = {Movement Disorders},
year = {2024},
doi = {10.1002/mds.29741}
}
EUVIMED